These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37718809)

  • 21. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
    Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
    Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A volumetric magnetic resonance imaging study of the amygdala in frontotemporal lobar degeneration and Alzheimer's disease.
    Whitwell JL; Sampson EL; Watt HC; Harvey RJ; Rossor MN; Fox NC
    Dement Geriatr Cogn Disord; 2005; 20(4):238-44. PubMed ID: 16088140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging correlates of pathology in corticobasal syndrome.
    Whitwell JL; Jack CR; Boeve BF; Parisi JE; Ahlskog JE; Drubach DA; Senjem ML; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    Neurology; 2010 Nov; 75(21):1879-87. PubMed ID: 21098403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration.
    Duignan JA; Haughey A; Kinsella JA; Killeen RP
    Semin Nucl Med; 2021 May; 51(3):264-274. PubMed ID: 33402272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers.
    Hüper L; Steinacker P; Polyakova M; Mueller K; Godulla J; Herzig S; Danek A; Engel A; Diehl-Schmid J; Classen J; Fassbender K; Fliessbach K; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Obrig H; Oeckl P; Prudlo J; Saur D; Anderl-Straub S; Synofzik M; Wagner M; Wiltfang J; Winkelmann J; Volk AE; ; Huppertz HJ; Otto M; Schroeter ML
    Alzheimers Dement; 2024 Jun; ():. PubMed ID: 38865340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration.
    Robinson JL; Porta S; Garrett FG; Zhang P; Xie SX; Suh E; Van Deerlin VM; Abner EL; Jicha GA; Barber JM; Lee VM; Lee EB; Trojanowski JQ; Nelson PT
    Brain; 2020 Sep; 143(9):2844-2857. PubMed ID: 32830216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
    Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
    Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential Neurotoxicity Related to Tetracycline Transactivator and TDP-43 Expression in Conditional TDP-43 Mouse Model of Frontotemporal Lobar Degeneration.
    Kukreja L; Shahidehpour R; Kim G; Keegan J; Sadleir KR; Russell T; Csernansky J; Mesulam M; Vassar RJ; Wang L; Dong H; Geula C
    J Neurosci; 2018 Jul; 38(27):6045-6062. PubMed ID: 29807909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyotrophic lateral sclerosis features predict TDP-43 pathology in frontotemporal lobar degeneration.
    Long Z; Irish M; Hodges JR; Halliday G; Piguet O; Burrell JR
    Neurobiol Aging; 2021 Nov; 107():11-20. PubMed ID: 34371283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
    Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
    Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral variant of frontotemporal dementia: Fundamental clinical issues associated with prediction of pathological bases.
    Miki T; Yokota O; Ishizu H; Kuroda S; Oshima E; Terada S; Yamada N
    Neuropathology; 2016 Aug; 36(4):388-404. PubMed ID: 26969837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Mesulam MM; Coventry CA; Bigio EH; Sridhar J; Gill N; Fought AJ; Zhang H; Thompson CK; Geula C; Gefen T; Flanagan M; Mao Q; Weintraub S; Rogalski EJ
    Brain; 2022 Jun; 145(6):2133-2148. PubMed ID: 35441216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Carter D; Cairns NJ
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
    Cervantes González A; Irwin DJ; Alcolea D; McMillan CT; Chen-Plotkin A; Wolk D; Sirisi S; Dols-Icardo O; Querol-Vilaseca M; Illán-Gala I; Santos-Santos MA; Fortea J; Lee EB; Trojanowski JQ; Grossman M; Lleó A; Belbin O
    Mol Neurodegener; 2022 Apr; 17(1):29. PubMed ID: 35395770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-stage differentiation between Alzheimer's disease and frontotemporal lobe degeneration: Clinical, neuropsychology, and neuroimaging features.
    Li P; Quan W; Wang Z; Liu Y; Cai H; Chen Y; Wang Y; Zhang M; Tian Z; Zhang H; Zhou Y
    Front Aging Neurosci; 2022; 14():981451. PubMed ID: 36389060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD.
    Alcolea D; Irwin DJ; Illán-Gala I; Muñoz L; Clarimón J; McMillan CT; Fortea J; Blesa R; Lee EB; Trojanowski JQ; Grossman M; Lleó A
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):180-186. PubMed ID: 30297518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI signatures of the frontotemporal lobar degeneration continuum.
    Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
    Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.